Advertisement

German firm BioNTech boosts 2021 vaccine supply forecast to 2 billion doses

AFP
AFP - [email protected]
German firm BioNTech boosts 2021 vaccine supply forecast to 2 billion doses
An employee administring a vaccine in Saxony. Photo: DPA

German company BioNTech, which developed the first coronavirus vaccine approved in the West, said Monday it expects to produce 2 billion doses in 2021, up from the previous forecast of 1.3 billion doses.

Advertisement

"We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021, which incorporates the updated six-dose label," said the company, referring to an additional dose that could be extracted from each vial of the vaccine.

European regulators last week approved doctors drawing six doses from each
vial, boosting dosage capacity by 20 percent.

The Mainz-based company, which developed the jab with US giant Pfizer, is planning to open a new factory in Marburg, Germany, in February, expected to ramp up production capacity by 750 million doses a year.

READ ALSO: Germany's BioNTech warns against delaying second vaccine dose

The site will join five other sites in Germany, Belgium and the US shared with Pfizer.

Advertisement

The company said it had shipped nearly 33 million doses by January 10th, more
than a month after Britain became the first Western nation to approve any vaccine on December 2nd.

BioNTech's announcement comes after the EU agreed to raise its orders of the vaccine by 200 million doses, with an option for another 100 million.

But the vaccination rollout has been criticised across Europe, with sluggish starts in nations like France and the Netherlands.

The company added that Covid-19 will "likely become an endemic disease", and that vaccines would need to fight against the emergence of new viral variants and a "naturally waning immune response".

The German company said last week that studies show its vaccine works against the new mutation found in variants uncovered in Britain and South Africa.

READ ALSO: Germany's BioNTech says vaccine works against new Covid-19 strains

More

Join the conversation in our comments section below. Share your own views and experience and if you have a question or suggestion for our journalists then email us at [email protected].
Please keep comments civil, constructive and on topic – and make sure to read our terms of use before getting involved.

Please log in to leave a comment.

See Also